Finance

Lists
NX1:ASX
Nexalis Therapeutics Ltd
A$0.013
0.00%
(0.00) 1D
Sep 10, 11:52:30 AM GMT+10  ·   AUD
All symbols
SymbolPriceChange% Change
Generating top insights for NX1...
Mkt. cap
3.62M
Avg. vol.
48.36K
Volume
0.00
52-wk high
A$0.03
52-wk low
A$0.01
EPS
-A$0.01
Shares outstanding
253.04M
Mkt. cap
3.62M
Avg. vol.
48.36K
Volume
0.00
52-wk high
A$0.03
52-wk low
A$0.01
EPS
-A$0.01
Shares outstanding
253.04M
News stories
From web sources and news partners
About Nexalis Therapeutics Ltd
CEO-
Employees-
Founded2016
Headquarters-
SectorPharmaceutical industry
Websiteinhalerx.com.au
Previous reportsAll values in AUD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in AUD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
217.49K
217.49K
315.05K
315.05K
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
376.83K
376.83K
637.88K
637.88K
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
182.51K
182.51K
235.88K
235.88K
Operating expense
559.06K
559.06K
903.79K
903.79K
Total operating expenses
559.06K
559.06K
903.79K
903.79K
Operating income
-341.56K
-341.56K
-588.73K
-588.73K
Other non operating income
-
-
-
-
EBT including unusual items
-382.22K
-382.22K
-648.97K
-648.97K
EBT excluding unusual items
-382.22K
-382.22K
-648.97K
-648.97K
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-13.90K
-13.90K
29.15K
29.15K
Net income
-382.22K
-382.22K
-648.97K
-648.97K
Net profit margin
-175.74%
-175.74%
-205.99%
-205.99%
Earnings per share
-
-
-
-
Interest and investment income
32.00
32.00
537.00
537.00
Interest expense
-40.69K
-40.69K
-60.77K
-60.77K
Net interest expenses
-40.66K
-40.66K
-60.24K
-60.24K
Depreciation and amortization charges
-
-
877.00
877.00
EBITDA
-
-
-587.86K
-587.86K
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps